Avid bioservices to participate in the credit suisse 31st annual healthcare conference

Tustin, calif., nov. 02, 2022 (globe newswire) -- avid bioservices, inc. (nasdaq:cdmo), a dedicated biologics contract development and manufacturing organization (cdmo) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the credit suisse 31st annual healthcare conference. nick green, president and chief executive officer of avid bioservices, will deliver a corporate presentation at the conference, which will take place november 7-10, 2022, in rancho palos verdes, ca.
CDMO Ratings Summary
CDMO Quant Ranking